Literature DB >> 22790606

Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.

B Wang1, J Taylor, M Ratnamohan, K McPhie, A Kesson, R Dixit, R Booy, Ac Hurt, Nk Saksena, D E Dwyer.   

Abstract

Although oseltamivir-resistant pandemic influenza A(H1N1)pdm09 is uncommon in immunocompetent individuals, a recent report from Newcastle, Australia, showed the first sustained community spread, from June to August 2011, of oseltamivir-resistant influenza A(H1N1)pdm09 virus carrying the H275Y neuraminidase (NA) mutation. To determine the frequency and the extent of this viral variant spread in the nearest major city to Newcastle, we performed a sequencebased genotypic assessment on samples from 143 oseltamivir untreated and 23 oseltamivir post-treatment individuals with influenza collected contemporaneously in Sydney, 120 km southwest of Newcastle. The detection of two of 143 (1.4%) community-derived samples containing H275Y suggests a low prevalence of oseltamivir-resistant influenza A(H1N1)pdm09 virus in the general community and no convincing evidence of spread of the NA H275Y-bearing influenza A(H1N1)pdm09 virus. In oseltamivir treated patients, oseltamivir-resistant influenza A(H1N1)pdm09 virus continue to emerge with three of 23 (13%) post-treatment samples containing the H275Y mutation. The observation of signature mutations and distinct phylogenetic relationship in full-length sequences of haemagglutinin and neuraminidase genes derived from 2011 strains against 2009 strains indicates continued genetic evolution and antigenic drift of the influenza A(H1N1)pdm09 viruses circulating in Australia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790606     DOI: 10.2807/ese.17.27.20210-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  8 in total

1.  Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections.

Authors:  Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

Review 2.  A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.

Authors:  Ding Yuan Oh; Aeron C Hurt
Journal:  Scientifica (Cairo)       Date:  2014-04-02

3.  A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein.

Authors:  Kris M White; Paul De Jesus; Zhong Chen; Pablo Abreu; Elisa Barile; Puiying A Mak; Paul Anderson; Quy T Nguyen; Atsushi Inoue; Silke Stertz; Renate Koenig; Maurizio Pellecchia; Peter Palese; Kelli Kuhen; Adolfo García-Sastre; Sumit K Chanda; Megan L Shaw
Journal:  ACS Infect Dis       Date:  2014-12-15       Impact factor: 5.084

4.  Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.

Authors:  Emi Takashita; Seiichiro Fujisaki; Noriko Kishida; Hong Xu; Masaki Imai; Masato Tashiro; Takato Odagiri
Journal:  Influenza Other Respir Viruses       Date:  2013-06-08       Impact factor: 4.380

5.  Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.

Authors:  Bruno Lina; Charles Boucher; Albert Osterhaus; Arnold S Monto; Martin Schutten; Richard J Whitley; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2018-01-15       Impact factor: 4.380

6.  Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.

Authors:  Momoko Mawatari; Reiko Saito; Akinobu Hibino; Hiroki Kondo; Ren Yagami; Takashi Odagiri; Ikumi Tanabe; Yugo Shobugawa
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

Review 7.  Clinical Implications of Antiviral Resistance in Influenza.

Authors:  Timothy C M Li; Martin C W Chan; Nelson Lee
Journal:  Viruses       Date:  2015-09-14       Impact factor: 5.048

Review 8.  Molecular diagnosis of respiratory viruses.

Authors:  Lucy K Somerville; V Mala Ratnamohan; Dominic E Dwyer; Jen Kok
Journal:  Pathology       Date:  2015-04       Impact factor: 5.306

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.